↓ Skip to main content

Cochrane Database of Systematic Reviews

Continuous renal replacement therapy (CRRT) for rhabdomyolysis

Overview of attention for article published in Cochrane database of systematic reviews, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
131 Mendeley
Title
Continuous renal replacement therapy (CRRT) for rhabdomyolysis
Published in
Cochrane database of systematic reviews, June 2014
DOI 10.1002/14651858.cd008566.pub2
Pubmed ID
Authors

Xiaoxi Zeng, Ling Zhang, Taixiang Wu, Ping Fu

Abstract

Rhabdomyolysis is a condition that is characterised by the breakdown of skeletal muscle tissue and leakage of intracellular myocyte contents into circulating blood. Rhabdomyolysis can lead to acute kidney injury (AKI) and is a potentially life-threatening condition. Studies have indicated that continuous renal replacement therapy (CRRT) may provide benefits for people with rhabdomyolysis by removing potentially damaging myoglobin and stabilising haemodynamic and metabolic status.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 130 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 20%
Other 14 11%
Student > Ph. D. Student 14 11%
Researcher 13 10%
Student > Bachelor 13 10%
Other 30 23%
Unknown 21 16%
Readers by discipline Count As %
Medicine and Dentistry 63 48%
Nursing and Health Professions 14 11%
Social Sciences 4 3%
Agricultural and Biological Sciences 3 2%
Psychology 3 2%
Other 16 12%
Unknown 28 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2016.
All research outputs
#7,554,564
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,784
of 8,923 outputs
Outputs of similar age
#88,999
of 188,537 outputs
Outputs of similar age from Cochrane database of systematic reviews
#170
of 204 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,537 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.